Blueprint Medicines (BPMC) PT Raised to $55 at Wells Fargo
Tweet
Share
E-mailGet Alerts BPMC Hot Sheet
Price: $129.46 --0%
Rating Summary:
11 Buy, 18 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Rating Summary:
11 Buy, 18 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Join SI Premium – FREE
Wells Fargo analyst Derek Archila raised the price target on Blueprint Medicines (NASDAQ: BPMC) to $55.00 (from $48.00) while maintaining a Equal Weight rating.
You May Also Be Interested In
- Designer Brands (DBI) PT Lowered to $6 at UBS
- Ser Educacional SA (SEER3:BZ) PT Raised to R$23 at JPMorgan
- Petroreconcavo SA (RECV3:BZ) PT Lowered to R$12 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
